wiki pageCreated: 2026-04-02T07:19:30By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-genes-c8a
📖 Wiki Page
gene593 wordssynced 2026-04-02
C8A
Introduction
C8A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
C8A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The C8A gene encodes the alpha chain of complement component 8 (C8α), a terminal complement protein essential for membrane attack complex (MAC) formation. C8 is composed of three chains (alpha, beta, and gamma) that form a heterotrimeric complex. The gene is located on chromosome 1p31.3 and encodes a protein of 579 amino acids [1].
C8 is a critical component of the complement terminal pathway. The alpha chain contains a hydrophobic region that inserts into the target cell membrane, while the gamma chain is a lipocalin-like protein. Together with C5b, C6, C7, and C9, C8 participates in forming the cytolytic MAC [2].
Function
The C8 alpha chain functions as:
Membrane Stabilization: Stabilizes the C5b-7 complex on the target cell membrane
Scaffold for C9: Provides a platform for C9 polymerization and pore formation
Pore Formation: Contributes to efficient membrane pore formation by the MAC
Lipid Binding: The alpha chain contains a lipophilic region that inserts into lipid bilayers
The complete C8 complex (αβγ) binds to C5b-7 to form C5b-8, which then allows C9 polymerization to form the mature MAC (C5b-9).
Disease Associations
Complement Deficiency
C8 Deficiency: Individuals with C8 deficiency have increased susceptibility to Neisseria infections, particularly Neisseria meningitidis
Recurrent Infections: Lack of functional MAC leads to impaired bacterial killing
Neurodegeneration
MAC-mediated Injury: Sublytic MAC formation can contribute to neuronal injury in various neurodegenerative conditions
Glial Activation: MAC deposition may activate glial cells and contribute to neuroinflammation
Expression
Tissue Distribution
Liver: Primary site of synthesis (hepatocytes)
Brain: Low baseline expression in [astrocytes](/entities/astrocytes) and [microglia](/cell-types/microglia-neuroinflammation)
Various tissues: Widely expressed at low levels
Regulation
C8 expression is upregulated during acute phase response
Inflammatory cytokines can modulate C8 synthesis
Genetics
C8A polymorphisms may affect complement activity levels
Rare variants cause hereditary C8 deficiency
Clinical Significance
Diagnostic Markers: C8 levels can be measured for complement deficiency workup
Therapeutic Potential: Modulating C8 activity may have applications in treating complement-mediated diseases
Background
The study of C8A has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.